A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma-Reference-Cited by-同舟云学术

A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma

Published:2024-02-14 Issue:5 Volume:59 Page:695-698
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hirose Asao,Koh Hideo,Nakamae Mika^ORCID,Nakashima Yasuhiro^ORCID,Nishimoto Mitsutaka^ORCID,Okamura Hiroshi,Makuuchi Yosuke^ORCID,Kuno Masatomo^ORCID,Takakuwa Teruhito,Ido Kentaro,Sakatoku Kazuki,Hino Masayuki,Nakamae Hirohisa^ORCID

Funder

MEXT | Japan Society for the Promotion of Science

the Project Mirai Cancer Research Grants

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41409-024-02231-4.pdf

Reference12 articles.

1. Bazarbachi A-H, Reef D, Narvel H, Patel R, Al Hamed R, Vikash S, et al. Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma. Clin Hematol Int. 2023;5:78–91.

2. Utsunomiya A. Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma. Front Microbiol. 2019;10:2235.

3. Nosaka K, Iwanaga M, Imaizumi Y, Ishitsuka K, Ishizawa K, Ishida Y, et al. Epidemiological and clinical features of adult T-cell leukemia–lymphoma in Japan, 2010–2011: A nationwide survey. Cancer Sci. 2017;108:2478–86.

4. Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T, et al. Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma. Bone Marrow Transpl. 2016;51:205–11.

5. Muranushi H, Shindo T, Hishizawa M, Tokunaga M, Wake A, Nakano N, et al. GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma. Bone Marrow Transpl. 2021;56:155–66.